Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340
TEVA-OLMESARTAN / HCTZ 12.5MG 20MG TABLET Resolved 2018-10-22 2020-06-11 65343
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Resolved 2018-10-22 2020-06-11 65346
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Resolved 2018-09-12 2020-06-11 61359
ACT OLOPATADINE 0.1% 0.1% SOLUTION Actual shortage 2018-10-23 2018-10-23 65519

Showing 181 to 200 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-10-25 2019-10-26 97256
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
TEVA-OLMESARTAN 20MG TABLET Discontinued 2020-06-11 2020-06-11 117497
TEVA-OLMESARTAN 40MG TABLET Discontinued 2020-06-11 2020-06-11 117500
TEVA-OLMESARTAN / HCTZ 40MG 12.5MG TABLET Discontinued 2020-06-11 2020-06-11 117516
TEVA-OLMESARTAN / HCTZ 20MG 12.5MG TABLET Discontinued 2020-06-11 2020-06-11 117513
TEVA-OLMESARTAN / HCTZ 40MG 25MG TABLET Discontinued 2020-06-11 2020-06-11 117519
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63986
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63989
ACT OXYCODONE CR 80MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63992
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63983
ACT OXYCODONE CR 5MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-22 2018-10-22 65328
ACT PROGESTERONE INJECTION 50MG SOLUTION Discontinued 2025-04-29 2025-04-29 256082

Showing 21 to 40 of 300